Effect of Veramyst and Olopadatine 0.2% Opthalmic Solution on Allergy Symptoms
This study has been completed.
Sponsor:
University of Chicago
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Robert Naclerio, University of Chicago
ClinicalTrials.gov Identifier:
NCT01007253
First received: November 3, 2009
Last updated: June 14, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |